patient meetings

A group of ROS1 patients from across Germany and the Netherlands meet regularly to discuss these questions. We are doing surprisingly well. Thanks to targeted treatments, we have all increased our life expectancy, mostly by several years! Leading ROS1 lung cancer specialists provide us with information about cutting edge treatments, clinical trials and research activities. With their help, we can develop survival strategies. So we can think long-term again.